Company:  TIMBER PHARMACEUTICALS, I ... (TMBR)
Form Type:  S-1
Filing Date:  7/1/2022 
CIK:  0001504167 
Address:  110 ALLEN ROAD, SUITE 401 
City, State, Zip:  BASKING RIDGE, New Jersey 07920 
Telephone:  914-205-3481 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.46  
Change: 
-0.07 (-4.58%)  
Trade Time: 
Dec 05  
Market Cap: 
$4.34M
Trade TMBR now with

© 2022  
Description of Business
Timber Pharmaceuticals, Inc. ("Timber", the "Company", "we", "us") is a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Our investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. We are initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis ("CI"), facial angiofibromas ("FAs") in tuberous sclerosis complex ("TSC"), and sclerotic skin diseases. Our lead mid to late-stage programs are TMB-001 and TMB-002. TMB-003 is our earliest stage program.
Register and access this filing in:     
  FORM S-1
    SUBJECT TO COMPLETION, DATED JULY 1, 2022
    TABLE OF CONTENTS
    ABOUT THIS PROSPECTUS
    CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS
    THE OFFERING
    Use of Proceeds
    Risk Factors
    RISK FACTORS
    USE OF PROCEEDS
    CAPITALIZATION
    DILUTION
    DESCRIPTION OF CAPITAL STOCK
    Transfer Agent and Registrar
    PLAN OF DISTRIBUTION
      Indemnification
    WHERE YOU CAN FIND MORE INFORMATION
    LEGAL MATTERS
    EXPERTS
    PART II
      Item 13. Other Expenses of Issuance and Distribution.
      Item 14. Indemnification of Directors and Officers.
      Item 15. Recent Sales of Unregistered Securities.
      Item 16. Exhibits.
      Item 17. Undertakings.
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 23.1
    Consent of Independent Registered Public Accounting Firm
  EXHIBIT FILING FEES